Eileen Fei is a strategic and results-oriented leader in global market access and strategic pricing, specializing in rare diseases and commercial expertise in specialty care. They held several key positions at Sanofi Genzyme, including Commercial Director for the Transplant & Oncology division in the Japan-Asia Pacific region, where they developed and executed commercial strategies for financial growth. Since 2019, Eileen has served as Senior Director of Global Market Access & Strategic Pricing for Rare Diseases at Sanofi Genzyme. Prior experience includes roles at Eli Lilly and Company, where they worked as a Marketing Consultant in Global Diabetes Marketing. Eileen is currently pursuing an MBA at China Europe International Business School and holds a BS in Pharmacy from Shanghai Medical University.
This person is not in any teams
This person is not in any offices